#Bio Therapeutic Drugs (TRBC level 5)

INK Videos Oct 28, 2021
INK Ultra Money Free: BioVaxys insiders bet on the haptenization of cancer and covid
During the last week of October we put the Healthcare sector in the spotlight. On Wednesday, we ventured into the biotech space where BioVaxys (BIOV) insiders are betting big on their firm's novel approach to tackling cancer and COVID-19. Join us as a Canadian Insider or INK Research member as we let the insiders guide us to opportunity this fall.
INK Videos Oct 27, 2021
BioVaxys insiders bet on the haptenization of cancer and covid
We are continuing with our mini-series on Healthcare stocks by venturing into the biotech space. BioVaxys insiders are betting big on their firm's novel approach to tackling cancer and COVID-19.
Real Vision Dec 08, 2021
Pfizer & BioNTech Share Results on Boosters as Job Openings Near All-Time High
With markets easing on Omicron fears this week and assets across the board beginning to recover from last week’s drawdowns, Pfizer and BioNTech both announced today the initial findings of the effectiveness of their boosters against the Omicron variant, demonstrating promising results of neutralizing the virus. The October JOLTS numbers also were released, showing that 4.2 million Americans quit their jobs, a decrease from the previous month, and openings increased to slightly over 11 million. 42 Macro founder and CEO Darius Dale analyzes the labor market’s recovery, COVID’s continuing impact on markets, the implications of the U.S. House passing legislation on increasing the debt ceiling limit, and more. Interviewed by Ash Bennington. Want to submit questions? Drop them right here on the Exchange: https://rvtv.io/3dAjdo6